Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer

SIMPLE SUMMARY: New blood vessel formation (angiogenesis) has a crucial role in tumour growth and spread. Bevacizumab is an anticancer therapy that targets angiogenesis by inhibiting the vascular endothelial growth factor (VEGF) and is approved for the treatment of metastatic breast cancer. However,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: López-Vega, José Manuel, Álvarez, Isabel, Antón, Antonio, Illarramendi, José Juan, Llombart, Antonio, Boni, Valentina, García-Velloso, María José, Martí-Climent, Josep María, Pina, Luis, García-Foncillas, Jesús
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307791/
https://ncbi.nlm.nih.gov/pubmed/34298725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143511
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky